by John Conrad | Nov 13, 2019 | Policy News, Uncategorized
On November 1, 2019 Crain’s Chicago Business published an op-ed “It’s time for Illinois to protect residents from this cancer-causing agent” by Nancy C. Loeb. Ms. Loeb’s misleading op-ed included a number of misstatements on the use of Ethylene Oxide (EO) for medical...
by John Conrad | Oct 24, 2019 | iBIO News, Policy News
On October 9th Governor Pritzker identified the life sciences industry as a key economic pillar in the Illinois Department of Commerce and Economic Opportunity’s (DCEO) five-year plan to revitalize the Illinois economy and build the workforce of the future. This was...
by John Conrad | Oct 2, 2019 | Policy News
Policymakers in Washington are debating reforms they claim will lower prescription drug prices. It’s important our elected leaders offer real solutions instead of partisan soundbites that mask the real harm to patients by their government-run scheme. The House of...
by John Conrad | Sep 27, 2019 | 2019 Fed Issue, Policy News
On Sept. 19, House Speaker Nancy Pelosi (D-San Francisco) unveiled legislation in the form of the Lower Drug Costs Now Act (H.R. 3) Illinois is home to over 45,000 researchers, doctors, lawyers and business women and men in the biopharma industry who have an...
by John Conrad | Sep 26, 2019 | Policy News
This Oped was originally published in Crain’s Chicago Business on September 6, 2019 John Pletz’s article (“Will these startups help biotech take root in Chicago?” Aug. 9) highlights a shift in the Illinois biotech community and underscores the need...
by John Conrad | Sep 25, 2019 | iBIO News, Policy News
iBIO along with The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA), the Medical Imaging & Technology Alliance (MITA) and a broad coalition of medical innovators, physician inventors, patient groups, and...
